Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0530 Transporter Info
Gene Name	CACNA1H
Transporter Name	Voltage-gated calcium channel alpha Cav3.2
Gene ID	8912
UniProt ID	O95180

Post-Translational Modification of This DT
Overview of CACNA1H Modification Sites with Functional and Structural Information
Sequence	M T E G A R A A D E V R V P L G A P P P G P A A L V G A S P E S P G A P G R E A E R G S E L G V S P S E S P A A E R G A E L G A D E E Q R V P Y P A L A A T V F F C L G Q T T R P R S W C L R L V C N P W F E H V S M L V I M L N C V T L G M F R P C E D V E C G S E R C N I L E A F D A F I F A F F A V E M V I K M V A L G L F G Q K C Y L G D T W N R L D F F I V V A G M M E Y S L D G H N V S L S A I R T V R V L R P L R A I N R V P S M R I L V T L L L D T L P M L G N V L L L C F F V F F I F G I V G V Q L W A G L L R N R C F L D S A F V R N N N L T F L R P Y Y Q T E E G E E N P F I C S S R R D N G M Q K C S H I P G R R E L R M P C T L G W E A Y T Q P Q A E G V G A A R N A C I N W N Q Y Y N V C R S G D S N P H N G A I N F D N I G Y A W I A I F Q V I T L E G W V D I M Y Y V M D A H S F Y N F I Y F I L L I I V G S F F M I N L C L V V I A T Q F S E T K Q R E S Q L M R E Q R A R H L S N D S T L A S F S E P G S C Y E E L L K Y V G H I F R K V K R R S L R L Y A R W Q S R W R K K V D P S A V Q G Q G P G H R Q R R A G R H T A S V H H L V Y H H H H H H H H H Y H F S H G S P R R P G P E P G A C D T R L V R A G A P P S P P S P G R G P P D A E S V H S I Y H A D C H I E G P Q E R A R V A H A A A T A A A S L R L A T G L G T M N Y P T I L P S G V G S G K G S T S P G P K G K W A G G P P G T G G H G P L S L N S P D P Y E K I P H V V G E H G L G Q A P G H L S G L S V P C P L P S P P A G T L T C E L K S C P Y C T R A L E D P E G E L S G S E S G D S D G R G V Y E F T Q D V R H G D R W D P T R P P R A T D T P G P G P G S P Q R R A Q Q R A A P G E P G W M G R L W V T F S G K L R R I V D S K Y F S R G I M M A I L V N T L S M G V E Y H E Q P E E L T N A L E I S N I V F T S M F A L E M L L K L L A C G P L G Y I R N P Y N I F D G I I V V I S V W E I V G Q A D G G L S V L R T F R L L R V L K L V R F L P A L R R Q L V V L V K T M D N V A T F C T L L M L F I F I F S I L G M H L F G C K F S L K T D T G D T V P D R K N F D S L L W A I V T V F Q I L T Q E D W N V V L Y N G M A S T S S W A A L Y F V A L M T F G N Y V L F N L L V A I L V E G F Q A E G D A N R S D T D E D K T S V H F E E D F H K L R E L Q T T E L K M C S L A V T P N G H L E G R G S L S P P L I M C T A A T P M P T P K S S P F L D A A P S L P D S R R G S S S S G D P P L G D Q K P P A S L R S S P C A P W G P S G A W S S R R S S W S S L G R A P S L K R R G Q C G E R E S L L S G E G K G S T D D E A E D G R A A P G P R A T P L R R A E S L D P R P L R P A A L P P T K C R D R D G Q V V A L P S D F F L R I D S H R E D A A E L D D D S E D S C C L R L H K V L E P Y K P Q W C R S R E A W A L Y L F S P Q N R F R V S C Q K V I T H K M F D H V V L V F I F L N C V T I A L E R P D I D P G S T E R V F L S V S N Y I F T A I F V A E M M V K V V A L G L L S G E H A Y L Q S S W N L L D G L L V L V S L V D I V V A M A S A G G A K I L G V L R V L R L L R T L R P L R V I S R A P G L K L V V E T L I S S L R P I G N I V L I C C A F F I I F G I L G V Q L F K G K F Y Y C E G P D T R N I S T K A Q C R A A H Y R W V R R K Y N F D N L G Q A L M S L F V L S S K D G W V N I M Y D G L D A V G V D Q Q P V Q N H N P W M L L Y F I S F L L I V S F F V L N M F V G V V V E N F H K C R Q H Q E A E E A R R R E E K R L R R L E R R R R S T F P S P E A Q R R P Y Y A D Y S P T R R S I H S L C T S H Y L D L F I T F I I C V N V I T M S M E H Y N Q P K S L D E A L K Y C N Y V F T I V F V F E A A L K L V A F G F R R F F K D R W N Q L D L A I V L L S L M G I T L E E I E M S A A L P I N P T I I R I M R V L R I A R V L K L L K M A T G M R A L L D T V V Q A L P Q V G N L G L L F M L L F F I Y A A L G V E L F G R L E C S E D N P C E G L S R H A T F S N F G M A F L T L F R V S T G D N W N G I M K D T L R E C S R E D K H C L S Y L P A L S P V Y F V T F V L V A Q F V L V N V V V A V L M K H L E E S N K E A R E D A E L D A E I E L E M A Q G P G S A R R V D A D R P P L P Q E S P G A R D A P N L V A R K V S V S R M L S L P N D S Y M F R P V V P A S A P H P R P L Q E V E M E T Y G A G T P L G S V A S V H S P P A E S C A S L Q I P L A V S S P A R S G E P L H A L S P R G T A R S P S L S R L L C R Q E A V H T D S L E G K I D S P R D T L D P A E P G E K T P V R P V T Q G G S L Q S P P R S P R P A S V R T R K H T F G Q R C V S S R P A A P G G E E A E A S D P A D E E V S H I T S S A C P W Q P T A E P H G P E A S P V A G G E R D L R R L Y S V D A Q G F L D K P G R A D E Q W R P S A E L G S G E P G E A K A W G P E A E P A L G A R R K K K M S P P C I S V E P P A E D E G S A R P S A A E G G S T T L R R R T P S C E A T P H R D S L E P T E G S G A G G D P A A K G E R W G Q A S C R A E H L T V P S F A F E P L D L G V P S G D P F L D G S H S V T P E S R A S S S G A I V P L E P P E S E P P M P V G D P P E K R R G L Y L T V P Q C P L E K P G S P S A T P A P G G G A D D P V
PTM type	X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation
Asparagine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence CACNA1H			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	192
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at CACNA1H Asparagine 192 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence CACNA1H			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	271
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at CACNA1H Asparagine 271 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence CACNA1H			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	1466
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at CACNA1H Asparagine 1466 has the potential to affect its expression or activity.
Phosphorylation
Serine	39 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence CACNA1H			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	49
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 49 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence CACNA1H			[2] , [3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	51
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 51 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence CACNA1H			[2] , [3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	53
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 53 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence CACNA1H			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	215
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 215 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence CACNA1H			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	475
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 475 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence CACNA1H			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	484
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 484 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence CACNA1H			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	558
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 558 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence CACNA1H			[6] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	561
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 561 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence CACNA1H			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	758
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 758 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence CACNA1H			[11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	783
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 783 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence CACNA1H			[12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	881
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 881 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence CACNA1H			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1071
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1071 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence CACNA1H			[13] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1073
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1073 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence CACNA1H			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1090
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1090 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence CACNA1H			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1091
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1091 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence CACNA1H			[2] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1099
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1099 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence CACNA1H			[2] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1103
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1103 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence CACNA1H			[14] , [15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1107
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1107 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence CACNA1H			[14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1108
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1108 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence CACNA1H			[14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1109
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1109 has the potential to affect its expression or activity.
PTM Phenomenon 21	Have the potential to influence CACNA1H			[14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1110
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1110 has the potential to affect its expression or activity.
PTM Phenomenon 22	Have the potential to influence CACNA1H			[14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1143
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1143 has the potential to affect its expression or activity.
PTM Phenomenon 23	Have the potential to influence CACNA1H			[14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1144
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1144 has the potential to affect its expression or activity.
PTM Phenomenon 24	Have the potential to influence CACNA1H			[3] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1168
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1168 has the potential to affect its expression or activity.
PTM Phenomenon 25	Have the potential to influence CACNA1H			[3] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1174
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1174 has the potential to affect its expression or activity.
PTM Phenomenon 26	Have the potential to influence CACNA1H			[17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1198
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1198 has the potential to affect its expression or activity.
PTM Phenomenon 27	Have the potential to influence CACNA1H			[18]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1278
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1278 has the potential to affect its expression or activity.
PTM Phenomenon 28	Have the potential to influence CACNA1H			[12] , [19]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1425
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1425 has the potential to affect its expression or activity.
PTM Phenomenon 29	Have the potential to influence CACNA1H			[19] , [20]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1426
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1426 has the potential to affect its expression or activity.
PTM Phenomenon 30	Have the potential to influence CACNA1H			[12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1587
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1587 has the potential to affect its expression or activity.
PTM Phenomenon 31	Have the potential to influence CACNA1H			[21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1805
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1805 has the potential to affect its expression or activity.
PTM Phenomenon 32	Have the potential to influence CACNA1H			[21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1822
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1822 has the potential to affect its expression or activity.
PTM Phenomenon 33	Have the potential to influence CACNA1H			[22]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1890
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1890 has the potential to affect its expression or activity.
PTM Phenomenon 34	Have the potential to influence CACNA1H			[23]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1905
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1905 has the potential to affect its expression or activity.
PTM Phenomenon 35	Have the potential to influence CACNA1H			[24]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1920
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1920 has the potential to affect its expression or activity.
PTM Phenomenon 36	Have the potential to influence CACNA1H			[14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1926
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1926 has the potential to affect its expression or activity.
PTM Phenomenon 37	Have the potential to influence CACNA1H			[12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1999
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 1999 has the potential to affect its expression or activity.
PTM Phenomenon 38	Have the potential to influence CACNA1H			[2] , [25]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	2057
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 2057 has the potential to affect its expression or activity.
PTM Phenomenon 39	Have the potential to influence CACNA1H			[14] , [25]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	2137
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Serine 2137 has the potential to affect its expression or activity.
Threonine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence CACNA1H			[26]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	170
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Threonine 170 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence CACNA1H			[27] , [28]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	749
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Threonine 749 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence CACNA1H			[27] , [28]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	751
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Threonine 751 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence CACNA1H			[3] , [16]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1175
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Threonine 1175 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence CACNA1H			[29] , [30]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1191
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Threonine 1191 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence CACNA1H			[21]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1806
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Threonine 1806 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence CACNA1H			[21]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1817
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Threonine 1817 has the potential to affect its expression or activity.
Tyrosine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence CACNA1H			[31]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	343
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Tyrosine 343 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence CACNA1H			[31]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	344
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Tyrosine 344 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence CACNA1H			[32]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	394
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Tyrosine 394 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence CACNA1H			[32]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	398
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Tyrosine 398 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence CACNA1H			[5]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	479
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Tyrosine 479 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence CACNA1H			[18]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1275
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Tyrosine 1275 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence CACNA1H			[25]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	2136
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at CACNA1H Tyrosine 2136 has the potential to affect its expression or activity.

References
1	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: CAC1H_HUMAN)
2	Phosphoproteomics reveals ALK promote cell progress via RAS/ JNK pathway in neuroblastoma. Oncotarget. 2016 Nov 15;7(46):75968-75980.
3	Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. EMBO J. 2015 Nov 12;34(22):2840-61.
4	Phosphosignature predicts dasatinib response in non-small cell lung cancer. Mol Cell Proteomics. 2012 Sep;11(9):651-68.
5	Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
6	An orthogonal proteomic survey uncovers novel Zika virus host factors. Nature. 2018 Sep;561(7722):253-257.
7	Dysregulation of splicing proteins in head and neck squamous cell carcinoma. Cancer Biol Ther. 2016;17(2):219-29.
8	Deep Coverage of Global Protein Expression and Phosphorylation in Breast Tumor Cell Lines Using TMT 10-plex Isobaric Labeling. J Proteome Res. 2017 Mar 3;16(3):1121-1132.
9	Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
10	Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics. Nat Commun. 2019 Jan 10;10(1):104.
11	Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column. Anal Sci. 2008 Jan;24(1):161-6.
12	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
13	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
14	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
15	Protein kinase A activity controls the regulation of T-type CaV3.2 channels by Gbetagamma dimers. J Biol Chem. 2009 Mar 20;284(12):7465-73.
16	Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer. PLoS One. 2018 Oct 2;13(10):e0204658.
17	Molecular basis for the modulation of native T-type Ca2+ channels in vivo by Ca2+/calmodulin-dependent protein kinase II. J Clin Invest. 2006 Sep;116(9):2403-12.
18	Tip-Based Fractionation of Batch-Enriched Phosphopeptides Facilitates Easy and Robust Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):46-54.
19	Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL. Blood Adv. 2018 Oct 9;2(19):2554-2567.
20	In-Depth Analyses of B Cell Signaling Through Tandem Mass Spectrometry of Phosphopeptides Enriched by PolyMAC. Int J Mass Spectrom. 2015 Feb 1;377:744-753.
21	Selective Enrichment of Cysteine-Containing Phosphopeptides for Subphosphoproteome Analysis. J Proteome Res. 2015 Dec 4;14(12):5341-7.
22	p38-MK2 signaling axis regulates RNA metabolism after UV-light-induced DNA damage. Nat Commun. 2018 Mar 9;9(1):1017.
23	Offline pentafluorophenyl (PFP)-RP prefractionation as an alternative to high-pH RP for comprehensive LC-MS/MS proteomics and phosphoproteomics. Anal Bioanal Chem. 2017 Jul;409(19):4615-4625.
24	Quantitative phosphoproteomic analysis of the PI3K-regulated signaling network. Proteomics. 2016 Jul;16(14):1992-7.
25	Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
26	Proteomic analysis of cell cycle progression in asynchronous cultures, including mitotic subphases, using PRIMMUS. Elife. 2017 Oct 20;6:e27574.
27	A strategy for large-scale phosphoproteomics and SRM-based validation of human breast cancer tissue samples. J Proteome Res. 2012 Nov 2;11(11):5311-22.
28	Phosphoproteome profiling revealed abnormally phosphorylated AMPK and ATF2 involved in glucose metabolism and tumorigenesis of GH-PAs. J Endocrinol Invest. 2019 Feb;42(2):137-148.
29	Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006 Nov 3;127(3):635-48.
30	Phosphoproteomics Profiling of Nonsmall Cell Lung Cancer Cells Treated with a Novel Phosphatase Activator. Proteomics. 2017 Nov;17(22):10.1002/pmic.201700214.
31	A fast sample processing strategy for large-scale profiling of human urine phosphoproteome by mass spectrometry. Talanta. 2018 Aug 1;185:166-173.
32	An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas. Cell Rep. 2015 Jun 23;11(11):1834-43.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence